Research Archive — Page 112 of 139
-
January 31, 2019
Cell death pathway implicated in bone marrow failure
Vanderbilt investigators have linked a specific form of programmed cell death to myelodysplastic syndrome, a type of bone marrow failure. -
January 24, 2019
Vanderbilt Prize winner Amon to speak at Jan. 31 lecture
Angelika Amon, PhD, recipient of the 2018 Vanderbilt Prize in Biomedical Science, will deliver her Vanderbilt Prize lecture at 4 p.m. Thursday, Jan. 31, in 208 Light Hall. -
January 17, 2019
Signals from the “conveyor belt”
Vanderbilt researchers propose that cellular signaling pathways are amplified by a “conveyor belt” mechanism that exchanges active and inactive enzymes. -
January 17, 2019
Pain relievers a risk for C. diff?
A link between anti-inflammatory drugs such as ibuprofen and C. diff infection suggests caution against overusing such drugs in patients at high risk for infection. -
January 17, 2019
DNA’s on/off switch
DNA-binding “switches” represent a fundamentally new method of communication between DNA-processing enzymes, Vanderbilt researchers propose. -
January 17, 2019
Building a pancreas
Vanderbilt investigators are defining the genetic programs that control the development of pancreatic beta cells — studies that could inform new cellular or regenerative therapies for diabetes. -
January 10, 2019
Study identifies novel genetic factors for colorectal cancer risk
A large-scale study conducted among East Asians and led by Vanderbilt researchers has identified multiple, previously unknown genetic risk factors for colorectal cancer.